These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism. Dale J, Thaulow E, Myhre E, Parry J. Thromb Haemost; 1983 Oct 31; 50(3):703-6. PubMed ID: 6689091 [Abstract] [Full Text] [Related]
26. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation. Yui Y, Hattori R, Takatsu Y, Nakajima H, Wakabayashi A, Kawai C, Kayama N, Hiraku S, Inagawa T, Tsubojima M. Circulation; 1984 Oct 31; 70(4):599-605. PubMed ID: 6434196 [Abstract] [Full Text] [Related]
30. Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction. De La Cruz JP, Villalobos MA, Escalante R, Guerrero A, Arrebola MM, Sánchez de La Cuesta F. Br J Pharmacol; 2002 Dec 31; 137(7):1082-8. PubMed ID: 12429581 [Abstract] [Full Text] [Related]
32. Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP. Burns GB, Dodge JA. Agents Actions; 1984 Jan 31; 14(1):102-8. PubMed ID: 6322546 [Abstract] [Full Text] [Related]
33. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Yu SM, Wu TS, Teng CM. Br J Pharmacol; 1994 Mar 31; 111(3):906-12. PubMed ID: 8019768 [Abstract] [Full Text] [Related]
34. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism. Macconi D, Morzenti G, Livio M, Morelli C, Cassina G, Remuzzi G. Lab Invest; 1985 Feb 31; 52(2):159-68. PubMed ID: 3155816 [Abstract] [Full Text] [Related]
36. Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. Schulman ES, Newball HH, Demers LM, Fitzpatrick FA, Adkinson NF. Am Rev Respir Dis; 1981 Oct 31; 124(4):402-6. PubMed ID: 6170242 [Abstract] [Full Text] [Related]
37. Lag-phase of arachidonic acid-induced secretion in responders and non-responders to the thromboxane-synthetase inhibitors: involvement of cyclic-AMP. Lecompte T, Joussemet M, Hainaut J. Thromb Res; 1984 Jul 01; 35(1):91-7. PubMed ID: 6089368 [No Abstract] [Full Text] [Related]
38. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro. De Clerck F, Beetens J, de Chaffoy de Courcelles D, Freyne E, Janssen PA. Thromb Haemost; 1989 Feb 28; 61(1):35-42. PubMed ID: 2546278 [Abstract] [Full Text] [Related]
39. Inhibition of platelet aggregation by 1-alkylimidazole derivatives, thromboxane A synthetase inhibitors. Kayama N, Sakaguchi K, Kaneko S, Kubota T, Fukuzawa T, Kawamura S, Yoshimoto T, Yamamoto S. Prostaglandins; 1981 Apr 28; 21(4):543-54. PubMed ID: 7196056 [Abstract] [Full Text] [Related]